88352-44-7

Usage

Uses

Used in Pharmaceutical Research and Development:
4-Oxazoleacetic acid, 2-(4-chlorophenyl)-5-(2-furanyl)-, ethyl ester is used as a research compound for its potential anticonvulsant and anti-inflammatory properties. It has been investigated in preclinical studies for its ability to treat conditions such as epilepsy and inflammation.
Used in Anticancer Applications:
In the field of oncology, 4-Oxazoleacetic acid, 2-(4-chlorophenyl)-5-(2-furanyl)-, ethyl ester is used as a cytotoxic agent against tumor cells. Its potential to inhibit the growth and proliferation of cancer cells has been explored, making it a promising candidate for cancer treatment.
Used in Inflammatory Disease Treatment:
4-Oxazoleacetic acid, 2-(4-chlorophenyl)-5-(2-furanyl)-, ethyl ester is used as an inhibitor of cellular inflammation pathways. Its potential to treat inflammatory diseases by reducing inflammation and modulating immune responses has been studied, offering a new avenue for therapeutic intervention in conditions such as arthritis and autoimmune disorders.
Further research is needed to fully understand the pharmacological properties and potential therapeutic applications of 4-Oxazoleacetic acid, 2-(4-chlorophenyl)-5-(2-furanyl)-, ethyl ester, ensuring its safety and efficacy in various medical fields.

InChI:InChI=1/C17H14ClNO4/c1-2-21-15(20)10-13-16(14-4-3-9-22-14)23-17(19-13)11-5-7-12(18)8-6-11/h3-9H,2,10H2,1H3

Upstream product

• 122-01-0 4-chloro-benzoyl chloride 
• 88352-87-8 N-(4-chlorobenzoyl)-(furan-2-ylcarbonyl)methylamine 
• 88352-86-7 (furan-2-ylcarbonyl)methylamine hydrochloride 
• 88352-43-6 ethyl 3-(4-chlorobenzoylamino)-4-(2-furyl)-4-oxobutyrate 

Downstream Products

• 113598-21-3 [2-(4-Chloro-phenyl)-5-(5-formyl-furan-2-yl)-oxazol-4-yl]-acetic acid ethyl ester 
• 88352-83-4 [2-(4-Chloro-phenyl)-5-furan-2-yl-oxazol-4-yl]-acetic acid dodecyl ester 
• 113598-19-9 3-pyridylmethyl 2-(4-chlorophenyl)-5-(2-furyl)oxazoleacetate 
• 88352-85-6 n-heptyl 2-[2-(4-chlorophenyl)-5-(furan-2-yl)-4-oxazolyl]acetate 
• 88352-84-5 n-butyl 2-[2-(4-chlorophenyl)-5-(furan-2-yl)-4-oxazolyl]acetate 
• 94797-19-0 2-[2-(4-Chloro-phenyl)-5-furan-2-yl-oxazol-4-yl]-propionic acid 
• 113598-18-8 [2-(4-Chloro-phenyl)-5-furan-2-yl-oxazol-4-yl]-acetyl chloride 
• 94797-17-8 2-[2-(4-Chloro-phenyl)-5-furan-2-yl-oxazol-4-yl]-2-methyl-propionic acid ethyl ester 
• 94797-12-3 2-[2-(4-Chloro-phenyl)-5-furan-2-yl-oxazol-4-yl]-propionic acid ethyl ester 
• 113598-24-6 ethyl 2-(4-chlorophenyl)-5-(5-sulfo-2-furyl)-4-oxazoleacetate 
• 113598-23-5 ethyl 5-(5-bromo-2-furyl)-2-(4-chlorophenyl)-4-oxazoleacetate 
• 113598-25-7 ethyl 2-phenyl-5-(2-tetrahydrofuryl)-4-oxazoleacetate 
• 88352-70-9 TA-1801A 
• 113598-20-2 2-[2-(4-Chloro-phenyl)-5-furan-2-yl-oxazol-4-yl]-butyric acid ethyl ester 

Relevant academic research and scientific papers

Synthesis of ethyl 2-(4-chlorophenyl)-5-(2-furyl)-4-oxazoleacetate, a hypolipidemic agent, and related compounds

A series of 2-aryl and 2-alkyl derivatives of 5-furyl-4-oxazoleacetic acid and their homologues having alkyl groups at the α-position of the acids were synthesized and evaluated for their hypolipidemic activities in Sprague-Dawley rats. On the basis of th

Furyloxazolylacetic acid derivatives and processes for preparing same

A furyloxazolylacetic acid derivative of the formula: STR1 wherein R1 is alkyl of one to 6 carbon atoms, cycloalkyl of 5 to 6 carbon atoms, phenyl or a substituted phenyl (said substituted phenyl being phenyl group substituted with one or two r